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Abstract Near complete reabsorption of filtered amino
acids is a main specialized transport function of the kidney
proximal tubule. This evolutionary conserved task is carried
out by a subset of luminal and basolateral transporters that
together form the transcellular amino acid transport
machinery similar to that of small intestine. A number of
other amino acid transporters expressed in the basolateral
membrane of proximal kidney tubule cells subserve either
specialized metabolic functions, such as the production of
ammonium, or are part of the cellular housekeeping
equipment. A new finding is that the luminal Na+-
dependent neutral amino acid transporters of the SLC6
family require an associated protein for their surface
expression as shown for the Hartnup transporter B0AT1
(SLC6A19) and suggested for the L-proline transporter
SIT1 (IMINOB, SLC6A20) and for B0AT3 (XT2,
SLC6A18). This accessory subunit called collectrin
(TMEM27) is homologous to the transmembrane anchor
region of the renin–angiotensin system enzyme ACE2 that
we have shown to function in small intestine as associated
subunit of the luminal SLC6 transporters B0AT1 and SIT1.
Some mutations of B0AT1 differentially interact with these
accessory subunits, providing an explanation for differential
intestinal phenotypes among Hartnup patients. The baso-
lateral efflux of numerous amino acids from kidney tubular
cells is mediated by heteromeric amino acid transporters
that function as obligatory exchangers. Thus, other trans-
porters within the same membrane need to mediate the net
efflux of exchange substrates, controlling thereby the net
basolateral amino transport and thus the intracellular amino
acid concentration.
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Different kidney amino acid transporter functions
Amino acids play central roles in the metabolism of all
organisms, in particular the 20 proteogenic amino acids
that are building blocks of proteins. Amino acids also
play an important role as substrates for energy produc-
tion, as substrates for the synthesis of other molecules,
such as compatible osmolytes and also as neurotrans-
mitters. For mammals, approximately half of the
proteogenic amino acids are essential, meaning that
they need to be taken up from the diet, since they
cannot be synthesized in the organism. Because free
amino acids present in the blood plasma are filtered at
the level of the kidney glomeruli in substantial amounts,
namely more than 50 g per day in humans, their
reabsorption by the kidney proximal tubules that
prevents their loss in the urine is a very important
function from the point of view of the organism
homeostasis [56]. This transepithelial transport from the
kidney tubular lumen into the extracellular space is
therefore a much conserved function of the proximal
tubule. A second amino acid transport function within the
kidney which has a direct impact on organism homeostasis
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is the cellular import and/or export of amino acids that are
metabolized by kidney cells. In that regard, an important
regulated transport function is the basolateral uptake of
glutamine along the more distal segments of the proximal
tubule which is required for the production of ammonia, a
substrate used by kidney tubular cells for the secretion of
protons [32]. Other amino acid transport functions
observed in tubular cells relate presumably either to
housekeeping and/or to additional specialized functions.
Although this has not been studied in detail, it appears
meaningful that it is another subset of mostly basolateral
transport proteins that accounts for these functions. Thus,
proximal kidney cells express, next to their housekeeping
amino acid transporters, a subset of specialized trans-
porters involved in metabolic functions (i.e., ammonium
and glutathione synthesis) and another subset that com-
poses the specialized proximal tubule amino acid reab-
sorption machinery (Fig. 1). A further degree of
complexity is given by the fact that the specialized
functions are not distributed uniformly along the proximal
tubule axis.
From structural reductionism to integrative function:
complementary perspectives
Over the past decades, amino acid transport functions have
been investigated using always the newly available techni-
ques to measure how these hydrophilic solutes cross the
lipophilic membranes. A first wave of information came
with the description of so-called transport systems that was
made possible by the availability of radio-labeled amino
acids and analytical quantification techniques used to
perform transport studies first in tissues and cells and then
using membrane vesicles [14, 33, 45]. A second wave of
information started during the 1990s when the molecular
identification of amino acid transporters was made possible
by complementary DNA cloning and cellular expression
techniques [8, 24, 25, 34, 55]. These new approaches
allowed the characterization of the function of amino acid
transporters in expression systems, the measurement of
their messenger RNA (mRNA) expression levels in tissues
and the production of antibodies to localize the protein. A
third wave of insight in amino acid transporter function has
started a few years ago with the determination of transport
protein structures [58, 59].
The physiological question of the transport function
remains, however, the central issue, at the molecular,
cellular, organ, and systemic levels. Characterization of
the functional role of amino acid transporters is necessary
for understanding life processes and for identifying dys-
functions and corresponding drug targets. The multiple
currently available approaches and future techniques are all
required to address these important questions using in
particular gene-modified animal models and also human
subjects.
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Fig. 1 Cellular model for the
reabsorption of amino acids
across a proximal kidney tubule
cell. Names of the involved
transporters and their human
gene are indicated. Most of them
have been shown to be
expressed mainly in the early
segments of mouse proximal
tubule (S1 and S2), with the
exception of SIT1 that is
expressed all along the proximal
tubule and of B0AT3 and
EAAT3 that are expressed
mainly in the later proximal
tubule (S2 and S3). AA0 neutral
amino acid, AA− anionic amino
acid, AA+ cationic amino acid,
Coll collectrin/TMEM27
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Luminal transporters and their associated proteins
Quantitatively, neutral amino acids represent >80% of the
free plasma amino acids and are all transported by the
luminal B0AT1 transporter (SLC6A19), though with differ-
ent apparent affinities (Fig. 1). This Na+-neutral amino acid
cotransporter (symport) with broad selectivity has been
identified a few years ago among previously orphan
members of the SLC6 family of sodium (and chloride)-
dependent neurotransmitter and amino acid transporters [7].
It is expressed in the luminal brush border membrane of the
early segments of the kidney proximal tubule and similarly
along the small intestine [39]. Its defect has been shown to
cause Hartnup disorder, an autosomal recessive condition
which is characterized by a urinary loss of neutral amino
acids [26, 42]. In some cases, this aminoaciduria is
accompanied by pellagra-like light-sensitive rashes, cere-
bellar ataxia, and/or other central nervous system (CNS)
manifestations. The skin and CNS symptoms appear to be
mostly compensated by niacin (nicotinamic acid/vitamin
B3) treatment and are thus considered to be due to a defect
in intestinal L-tryptophan uptake that leads to a consecutive
defect in endogenous niacin production [8].
Sodium-driven reuptake of neutral amino acids by the
proximal kidney tubule is analogous to the reuptake of
D-glucose. Unlike in intestine, in kidney uptake of luminal
D-glucose is mediated by two transporters, the low affinity
SGLT2 that is expressed along the two first convoluted
segments of the proximal tubule (S1 and S2) and the high
affinity SGLT1 that is expressed essentially in the later
straight proximal tubule segment S3 [57]. This sequential
distribution of a low affinity and a high affinity transporter
along the proximal tubule appears meaningful in order to
recover a maximum of glucose from the filtrate and it is
interesting to observe that such a sequential arrangement
of a low and a high apparent affinity transporter is also
present for the reuptake of di- and tripeptides, namely with
the low affinity PEPT1 in the early proximal tubule and
the higher affinity PEPT2 in the late proximal tubule [17].
In the case of neutral amino acid transporters, it is
B0AT1 (SLC6A19) that displays a relatively low apparent
affinity for its substrates [4, 11] and that is expressed in the
early proximal tubule segments. Interestingly, the structur-
ally related transporter XT2 displays along the proximal
tubule an axial complementary arrangement with B0AT1
and its gene SLC6A18 is arranged in tandem with SLC6A19
(B0AT1) on chromosome 5p15 in human [39]. In a knock-
out mouse model of Slc6a18, a clear defect in glycine
uptake was observed at the level of the late proximal tubule
[36]. Together with our unpublished data on Slc6a18 (XT2)
expression and on the Slc6a18 null mouse reanalysis, this
indicates that Slc6a18 has in mice the function of a high
affinity neutral amino acid transporter analogous to that of
SGLT1 for glucose and PEPT2 for peptides. Thus, we
propose to rename XT2 B0AT3 [36] (Fig. 1). The functional
importance of this transporter in humans is, however,
questioned by the fact that a substantial proportion of the
population displays a nonsense single nucleotide polymor-
phism in this gene with which no phenotype has as yet been
associated [20].
The expression of B0AT1, as well as that of B0AT3 and
SIT1 (see below), has been shown recently to depend in
mouse proximal tubule on the expression of collectrin
(Tmem27), a relatively short type I transmembrane protein
(25 kD) that is approximately 40% identical with the
membrane anchor region of the renin–angiotensin system
enzyme ACE2 [19, 29]. That collectrin is associated with
B0AT1 in the kidney brush border membranes of wild-type
mice has been shown by co-immunoprecipitation [19]. In
collectrin knock-out mice, the lack of this associated
protein leads to the quasi absence of B0AT1 from the
luminal membrane and to a very strong reduction of B0AT1
at the cellular level, suggesting that association with
collectrin stabilizes B0AT1 and allows its transfer to the
luminal brush border membrane. Functionally, the lack of
collectrin leads to a massive urinary loss of neutral amino
acids that even leads to osmotic diuresis. It is relevant to
notice that collectrin knock-out mice lose a substantial
amount of L-proline in the urine and that their urinary
glycine is also very high. These findings suggest that the
defect in collectrin affects also transporters participating to
the reabsorption of L-proline (SIT1, see below) and glycine
(B0AT3, Slc6a18).
Because collectrin is not expressed in substantial
amounts in small intestine and B0AT1 is normally highly
expressed in the brush border membrane of enterocytes of
collectrin knock-out mice, others and we postulated that
another protein can substitute in intestine for the role that
collectrin plays in kidney tubule [19, 28]. Having demon-
strated that the carboxypeptidase ACE2 colocalizes with
B0AT1 in small intestine and can be coprecipitated with
B0AT1, we tested whether ACE2 absence impacts on the
expression of B0AT1. Indeed, B0AT1 turned out to be
absent from the brush border membrane of ace2 null mice
[12]. Thus, ACE2 is the accessory subunit of these SLC6
transporters in small intestine playing an equivalent role to
that of collectrin in kidney. This suggests the possibility
that during evolution, a gene duplication of ACE2 allowed
the separation of the carboxypeptidase function of ACE2
from its amino acid transporter subunit function allowing
independent regulation of the two functions in kidney.
Another member of the same SLC6 amino acid transport-
er cluster, SLC6A20 in human, has been identified as the
molecular correlate of system IMINO, mediating the
cotransport of L-proline presumably with two Na+ and one
Cl− [27, 46]. This transporter called SIT1 or IMINOB was
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shown to localize to the brush border membrane of the
proximal tubule in mice by immunofluorescence [39]. As
expected for system IMINO, it transports also hydroxy-
L-proline and betaine with a relatively high apparent affinity
but does not transport glycine. In rodents, a relative recent
gene duplication has led to the expression of XT3 (IMINOK,
Slc6a20b), a very similar transporter that localizes as well to
the kidney proximal tubule brush border membrane but the
function of which has not yet been characterized. As
mentioned above, SIT1/IMINOB appears to require, as
B0AT1 and B0AT3, the association with collectrin for its
surface expression in kidney. This is at least suggested by the
low brush border membrane expression of SIT1/IMINOB in
collectrin knock-out mice and by the large urinary L-proline
loss in these animals [19].
Besides the sodium-dependent SLC6 family transporters
mentioned above, proton cotransporters are also expressed in
the kidney brush border membrane. The characterization of
their function has been rendered more difficult by the fact that
the proton gradient across the luminal membrane of proximal
tubule cells depends on the activity of the sodium–proton
exchanger NHE3, such that in many assays, their transport
function first appeared to be Na+ dependent. The first kidney
H+-dependent transporters to be identified were the peptide
transporters PEPT1 and PEPT2 [18]. Their function in
epithelia is complementary to that of amino acid transporters
and, in the case of PEPT1, quantitatively very important for
the absorption of amino acids across small intestine enter-
ocytes. Within these epithelial cells, di- and tripeptides are
mostly hydrolyzed and then released as free amino acids into
the extracellular space [16]. More recently, transporters
corresponding to the already previously suggested imino
acid carrier that cotransport imino acids or glycine with a
proton were identified and named PAT1 and PAT2 [1, 5].
Interestingly, PAT1 was first identified in neurons where it
functions as a lysosomal amino acid transporter and was
correspondingly first named LYAAT [41]. Functionally, the
imino acid carrier is expected to be localized in the early
segments of the proximal tubule where a recent report by
Australian groups just localized PAT2 [9, 13, 23].
In contrast to the neutral amino acids discussed above,
cationic amino acids and the disulfide-linked L-cysteine dimer
L-cystine enter the epithelial cells along their (electro)-
chemical gradient via the cystinuria transporter (b0,+AT).
This transporter is made of a catalytic subunit belonging to
the SLC7 family and a disulfide linked accessory subunit
referred to as heavy chain and called rBAT (SLC3A1).
Similarly to the basolateral heterodimeric exchangers of the
SLC7/SLC3 family (see below), it functions as an obligatory
antiporter and specifically exchanges its cationic substrates
or L-cystine against intracellular neutral amino acids. How
mechanistically this transporter can preferentially perform a
heteroexchange of cationic amino acids or cystine against
neutral amino acids is still a matter of debate [49]. The
hypothesis that we prefer is that heteroexchange is favored
by the cooperation of two heterodimeric transporters forming
a heterotetramer [21].
The luminal influx of anionic amino acids requires another
transporter that has been identified as being EAAT3 (EAAC1,
SLC1A1) [25]. This transporter has been shown to cotrans-
port its substrates with three Na+ ions and one proton in
exchange for one K+ ion [60]. Its expression at the luminal
membrane of proximal tubule cells follows a gradient toward
the late part of the proximal tubule [43]. Unlike the SLC6
and SLC7 transporters mentioned above, no SLC1 associat-
ed transmembrane protein has been identified so far.
However, the GTRAP3-18 protein that associates to EAAT3
C terminus appears to be expressed also in kidney [10].
ASCT2 is a Na+-dependent exchanger of neutral amino
acids that belongs to the SLC1 family and has been shown
to be expressed at the mRNA level in kidney. One report
has suggested that it localizes to the brush border
membrane [2, 52]. Its potential role in epithelial transport
is not clear and warrants further study.
Cooperation of basolateral transporters for a controlled
amino acid efflux
It is well established that the basolateral heterodimeric
obligatory amino acid exchanger y+LAT1-4F2hc plays an
important role for the transepithelial transport of its cationic
substrates which it transports out of the cells in exchange for
extracellular neutral amino acids and Na+ [35, 50]. The
functional importance of this electroneutral exchange for
transcellular cationic amino acid transport is demonstrated by
the autosomal recessive disease lysinuric protein intolerance
that is caused by mutations of the y+LAT1 gene (SLC7A7)
[6, 51]. Lysinuric protein intolerance is characterized next to
the urinary loss of L-arginine, L-ornithine, and L-lysine also
by a poor intestinal absorption of these amino acids. This
leads to low plasma concentrations of these amino acids and
to an impaired function of the urea cycle and hyper-
ammonemia [47]. The other basolateral heterodimeric
obligatory amino acid exchanger belonging to the amino
acid absorption machinery is LAT2-4F2hc [40]. It shares
with y+LAT1-4F2hc the same accessory subunit (4F2hc) and
also shows the same localization along the proximal kidney
tubule [3]. Furthermore, it apparently displays similarly high
levels of mRNA and protein expression. As yet, no genetic
condition with impaired LAT2 function has been identified,
but knock down experiments of LAT2 performed in the
proximal tubule OK cell line model have shown a reduction
of transepithelial L-cysteine transport [22].
Considering that the function of the proximal tubule amino
acid reabsorption machinery is a vectorial transepithelial
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transport, whereas these heterodimeric transporters only
exchange amino acids, it is necessary to postulate the presence
of parallel transporters within the same membrane that can
unidirectionally recycle influx substrates of these exchangers
back out of the cell. It is interesting to consider that from a
global amino acid transport point of view, these directional
transporters can control the rate of net amino acid transport,
whereas the exchangers only modulate the relative concen-
tration of individual amino acids [54].
One transporter that fulfils the criteria to be considered a
basolateral directional amino acid efflux pathway is TAT1
(SLC16A10). This transporter has been shown to colocalize
in the proximal kidney tubule with the two exchangers
mentioned above (Fig. 1) [37]. It has been shown in the
Xenopus laevis oocyte expression system to function as
facilitated diffusion pathway (uniport) for aromatic amino
acids [38]. It’s recycling function and cooperation with
LAT2-4F2hc has also been demonstrated in the same
expression system [37]. Indeed, its coexpression enabled
LAT2-4F2hc to release endogenous amino acids from
oocytes to the exterior in the absence of amino acids in the
buffer. This indicates that aromatic amino acids that exit the
cell via TAT1 can be recycled back into the cell interior in
exchange for intracellular amino acids, before diffusing away
from the membrane. This very efficient substrate recycling
motivated us to investigate the possibility that TAT1 not only
functionally cooperates with LAT2-4F2hc but that it would
also physically interact. However, all attempts of co-
immunoprecipitation and cross-linking failed to reveal such
a physical interaction [37].
Since the transport substrates of TAT1 are high affinity
uptake substrates for LAT2-4F2hc and y+LAT1-4F2hc, TAT1
could theoretically suffice to support their function in kidney
proximal tubule. To address this possibility, we have
analyzed the plasma and urinary amino acid concentration
in TAT1 (Slc16a10) null mice. These experiments revealed
that the fractional reabsorption of most amino acids,
including that of most obligatory exchanger substrates of
LAT2-4F2hc is normal (Ramadan et al., unpublished results).
From these results, we deduce that at least one additional
transporter capable of recycling exchanger substrates, prob-
ably another uniport, is or can be expressed at a sufficiently
high level in the same basolateral membrane to drive net
amino acid transport.
Amino acid transporters involved in uptake/release
of amino acids metabolized in proximal kidney
tubule cells
Next to its transport functions, the proximal tubule exerts
also many metabolic functions. The ones leading to
substantial amino acid fluxes and thus transports are (a)
the production of ammonia and bicarbonate from L-
glutamine, (b) gluconeogenesis mostly also using as amino
acid substrate L-glutamine, (c) L-arginine production from
citrulline, (d) L-tyrosine production from L-phenylalanine,
and (e) L-serine production from glycine [15, 31, 48, 53].
The regulation of amino acid transporters in the context
of acidosis has been investigated, since it was expected that
the transport of the ammonia precursor L-glutamine would
be induced [32, 44]. In a broad study, we analyzed the
potential regulation of amino acid transporters in the
proximal kidney tubule of mice rendered acidotic with
NH4Cl. The basolateral L-glutamine transporter SNAT3
(SLC38A3) was shown to be strongly upregulated by this
treatment. Interestingly, not only its total amount was
increased but also its localization was extended from the
late proximal S3 segment into the earlier S2 portion [32]. It
is not surprising that the regulated uptake of L-glutamine as
precursor of a metabolic function is through the basolateral
membrane, since the availability of this substrate should not
depend on its concentration in the urinary filtrate from
which it is removed already to a large extent in the early S1
segment. The only other amino acid transporter next to
SNAT3 that was substantially regulated by acidosis is the
cationic amino acid efflux pathway y+LAT1 that was
downregulated at the protein level.
Conclusions and future directions
Our current model of transcellular amino acid reabsorption
by the proximal tubule cells is shown in Fig. 1 and lacks
only few elements to be potentially complete. The luminal
influx of amino acids is mediated by a series of transporters
with uphill transport function, which is fuelled by the
cotransport of Na+ or H+. An exception to this rule is
represented by b0,+AT-rBAT which functions as an obliga-
tory exchanger transporting cationic amino acids and
cystine along their electrical and chemical gradients into
the cells, respectively, in exchange for intracellular neutral
amino acids. An open question is the mechanism that
allows b0,+AT1 to preferentially perform heteroexchange of
cationic amino acids or cystine with neutral amino acids
[21, 49].
The description of the function of B0AT3 (SLC6A18,
formerly XT2) allows us to attribute to this transporter the
function of a high affinity broad selectivity neutral amino
acid transporter that complements the function of B0AT1
along the later segments of the proximal tubule (Singer et
al., submitted). Whereas in mice the absence of B0AT3
leads to a substantial aminoaciduria, a frequent nonsense
mutation (Y319X) leading presumably to the absence of
functional B0AT3 transporter in a substantial percentage of
the Japanese population has as yet not been associated with
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any pathological finding [20]. More detailed analysis of the
phenotype of homozygous carriers will reveal whether
B0AT3 still has a recognizable amino acid transport
function in humans or not.
Another open question is the precise relative role of the
two H+-dependent transporters PAT1 (SLC36A1) and PAT2
(SLC36A2). It is possible that they represent low (PAT1)
and high affinity (PAT2) transporters and a recent study
suggests that the high affinity transporter PAT2 (SLC36A2)
is localized to the early proximal tubule whereas PAT1
(SLC36A1) would be the intestinal transporter [9].
Compared with the luminal amino acid influx step, the
efflux step across the basolateral membrane is not as well
known, actually for several reasons. One cause is that
cellular influx measurements are technically easier to
perform and interpret than efflux measurements. A second
reason is that a reliable technique to produce luminal brush
border membrane vesicles has allowed the study of the
function of apical transport proteins independently of the
basolateral transporters [33]. Practically, the luminal uptake
of amino acids probably requires less physiological control
than the basolateral efflux, since from a systemic point of
view, luminal amino acids need to be taken up just as much
as possible, whereas the basolateral efflux needs to
maintain a relatively stable amino acid gradient across the
cellular membrane. Indeed, whereas some amino acids
display similar concentrations within and outside of the
cells, some display an asymmetric distribution. This is in
particular the case for the anionic amino acids which are
present at much higher concentrations in the cytosol than in
the extracellular space, despite the fact that their charge
would predict just the opposite. On the other hand, cationic
amino acids are not more concentrated in the cytosol
compared with plasma, despite of their charge that would
drive an intracellular accumulation. Thus, an important
function of the basolateral efflux machinery is to preserve
this transmembrane amino acid concentration asymmetry.
Two transporters that appear to play an important role for
the control of the intracellular concentration of the spectrum
of different neutral and cationic amino acids are the
obligatory exchangers LAT2-4F2hc (exchange of neutral
amino acids) and y+LAT1-4F2hc (electroneutral exchange
of intracellular cationic amino acids against extracellular
neutral amino acids + Na+). In parallel to these basolateral
exchange transporters, (an) other transporter(s) that can
function as unidirectional amino acid efflux pathway(s)
needs to be present to allow a net vectorial transport. Which
transporter(s) fulfil(s) this function is not yet fully estab-
lished. We have shown, using the X. laevis oocyte
expression system, that the aromatic amino acid transporter
TAT1 that is present in the proximal kidney tubule and
small intestine basolateral membranes is capable of fulfill-
ing this function [37]. However, the TAT1 knock-out mouse
does not show the dramatic change in urinary amino acid
concentrations that would be expected, if TAT1 was the
only transporter exerting the recycling function necessary to
activate the efflux via the exchangers LAT2-4F2hc and
y+LAT1-4F2hc. Another candidate for this recycling func-
tion is LAT4 (Slc43a2) which we have also shown to be
able to cooperate with LAT2 in the X. laevis oocyte
expression system [37]. Clearly more work is required to
fully understand the controlled efflux of amino acids
through the basolateral membrane of transporting epithelia.
Yet another challenging question is how anionic amino
acids are released from epithelial cells, maintaining the very
high concentration gradient between the cells and the
extracellular space. Transporters from two families have been
proposed to potentially be involved in this controlled efflux. In
particular is AGT1 (SLC7A13), a gene product belonging to
the family of heterodimeric amino acid exchangers to which
LAT2 and y+LAT1 belong, but the putative heavy chain of
which has not been identified. Its anionic amino acid
transport function could only be revealed upon fusing it to
the “heavy chains” rBAT or 4F2hc. However, the question
whether it functions as obligatory exchanger has not been
addressed [8, 30]. Also, a potential role of the two members
of the SLC1 family EAAT1 (SLC1A3) and ASCT2
(SLC1A5) for the efflux of anionic amino acids has been
proposed [56]. However, a clear concept as to how the net
efflux of anionic amino acids through the basolateral
membrane of proximal kidney tubule cells takes place and
is controlled has not been put forward yet.
Considering the important progress that the identification
and characterization of presumably most amino acid trans-
porters represents, it appears now to be important to
understand more quantitatively their function and cooper-
ation within cells, also in respect of local amino acid
concentrations. Importantly, transporters not only control
the flux of amino acids across transporting epithelia such as
that of the proximal kidney tubule but also between the
organs of the organism. Thus, they control the availability
of these substrates and protein building blocks that play a
central role in cell growth control in physiology and
pathophysiology. Increasing our knowledge about the
mechanisms that govern amino acid transport across
epithelia and also their homeostasis in the organism will
require the development of additional new techniques to
follow accurately their local concentrations. To integrate the
resulting large amount of complex data on amino acid
fluxes and on transporter kinetics and regulatory behavior,
complementary modeling approaches will be required.
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